B7-H3 (Enoblituzumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7607783

The Humanized Monoclonal anti-B7-H3 (Enoblituzumab Biosimilar) antibody has been validated for ELISA and FACS. It is suitable to detect B7-H3 (Enoblituzumab Biosimilar) in samples from Human.

Quick Overview for B7-H3 (Enoblituzumab Biosimilar) antibody (Biotin) (ABIN7607783)

Target: B7-H3 (Enoblituzumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This B7-H3 (Enoblituzumab Biosimilar) antibody is conjugated to Biotin

Application: ELISA, Flow Cytometry (FACS)

Product Details anti-B7-H3 (Enoblituzumab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-B7-H3 (enoblituzumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Target Details for B7-H3 (Enoblituzumab Biosimilar)

Target: B7-H3 (Enoblituzumab Biosimilar)

Alternative Name: enoblituzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:B7-H3,CD276,B7 homolog 3
Synonyms Antibody:MG-A271, MGA271